MDT241129P76000
- 0.08
- 0.000.00%
Medtronic Newsroom
Unusual Options Activity: SPOT, MOD and Others Attract Market Bets, SPOT V/OI Ratio Reaches 90.4
With 85% Institutional Ownership, Medtronic Plc (NYSE:MDT) Is a Favorite Amongst the Big Guns
Barclays Adjusts Price Target on Medtronic to $109 From $105
Australia Diabetes Market Forecasts and Company Analysis 2024-2032, Novo Nordisk, Eli Lilly, Roche, Abbott Laboratories, Insuletn, Dexcom, Medtronic, Ypsomed
S&P 500, Dow Hit Records Right After Open | Live Stock
Medtronic Awarded 3-Year VA Contract To Expand GI Genius AI Technology To Enhance Colorectal Cancer Detection In Veterans
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Looking Into Medtronic's Recent Short Interest
Market Climbs, Bitcoin Close to $100k | Live Stock
Truist Financial Maintains Medtronic(MDT.US) With Hold Rating
Truist Financial Sticks to Their Hold Rating for Medtronic (MDT)
Bitcoin Hits $99k, Thursday Market Whiplash Following Nvidia Price | Wall Street Today
Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock
Medtronic Acquires Articulating Instrument Maker Fortimedix Surgical
Here's Why Medtronic (MDT) Is a Strong Value Stock
A Quick Look at Today's Ratings for Medtronic(MDT.US), With a Forecast Between $87 to $105
Medtronic's Insulin Pen App Gains FDA Clearance
Nvidia Forward Guidance Was Not Perfect, Market Flat | Wall Street Today
Medtronic Plc (MDT): A Key Player in Ken Griffin's Portfolio With Steady Growth
Medtronic Is Maintained at Outperform by Bernstein